IRIS Accounts Production v25.1.4.42 11612511 Board of Directors 1.11.23 31.10.24 31.10.24 false true false false true false Ordinary 1.00000 Ordinary B 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh116125112023-10-31116125112024-10-31116125112023-11-012024-10-31116125112022-10-31116125112022-11-012023-10-31116125112023-10-3111612511ns15:EnglandWales2023-11-012024-10-3111612511ns14:PoundSterling2023-11-012024-10-3111612511ns10:Director12023-11-012024-10-3111612511ns10:PrivateLimitedCompanyLtd2023-11-012024-10-3111612511ns10:SmallEntities2023-11-012024-10-3111612511ns10:AuditExempt-NoAccountantsReport2023-11-012024-10-3111612511ns10:SmallCompaniesRegimeForDirectorsReport2023-11-012024-10-3111612511ns10:SmallCompaniesRegimeForAccounts2023-11-012024-10-3111612511ns10:FullAccounts2023-11-012024-10-3111612511ns10:OrdinaryShareClass12023-11-012024-10-3111612511ns10:OrdinaryShareClass22023-11-012024-10-3111612511ns5:CurrentFinancialInstruments2024-10-3111612511ns5:CurrentFinancialInstruments2023-10-3111612511ns5:ShareCapital2024-10-3111612511ns5:ShareCapital2023-10-3111612511ns5:RetainedEarningsAccumulatedLosses2024-10-3111612511ns5:RetainedEarningsAccumulatedLosses2023-10-3111612511ns10:RegisteredOffice2023-11-012024-10-3111612511ns5:PlantMachinery2023-11-012024-10-3111612511ns5:ComputerEquipment2023-11-012024-10-3111612511ns5:PlantMachinery2023-10-3111612511ns5:ComputerEquipment2023-10-3111612511ns5:PlantMachinery2024-10-3111612511ns5:ComputerEquipment2024-10-3111612511ns5:PlantMachinery2023-10-3111612511ns5:ComputerEquipment2023-10-3111612511ns5:WithinOneYearns5:CurrentFinancialInstruments2024-10-3111612511ns5:WithinOneYearns5:CurrentFinancialInstruments2023-10-3111612511ns5:AcceleratedTaxDepreciationDeferredTax2024-10-3111612511ns5:AcceleratedTaxDepreciationDeferredTax2023-10-3111612511ns5:DeferredTaxation2023-11-012024-10-3111612511ns5:DeferredTaxation2024-10-3111612511ns10:OrdinaryShareClass12024-10-3111612511ns10:OrdinaryShareClass22024-10-31116125111ns10:Director12023-10-31116125111ns10:Director12022-10-31116125111ns10:Director12023-11-012024-10-31116125111ns10:Director12022-11-012023-10-31116125111ns10:Director12024-10-31116125111ns10:Director12023-10-31
REGISTERED NUMBER: 11612511 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED

31 OCTOBER 2024

FOR

DR NEIL RUPARELIA LTD

DR NEIL RUPARELIA LTD (REGISTERED NUMBER: 11612511)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2024










Page

Balance Sheet 1

Notes to the Financial Statements 3


DR NEIL RUPARELIA LTD (REGISTERED NUMBER: 11612511)

BALANCE SHEET
31 OCTOBER 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 5 2,492 3,540

CURRENT ASSETS
Debtors 6 253,286 180,811
Cash at bank and in hand 25,443 61,341
278,729 242,152
CREDITORS
Amounts falling due within one year 7 94,364 36,705
NET CURRENT ASSETS 184,365 205,447
TOTAL ASSETS LESS CURRENT
LIABILITIES

186,857

208,987

PROVISIONS FOR LIABILITIES 8 623 -
NET ASSETS 186,234 208,987

CAPITAL AND RESERVES
Called up share capital 9 200 200
Retained earnings 186,034 208,787
SHAREHOLDERS' FUNDS 186,234 208,987

DR NEIL RUPARELIA LTD (REGISTERED NUMBER: 11612511)

BALANCE SHEET - continued
31 OCTOBER 2024


The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 October 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 October 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 8 July 2025 and were signed on its behalf by:





Dr N Ruparelia - Director


DR NEIL RUPARELIA LTD (REGISTERED NUMBER: 11612511)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 OCTOBER 2024


1. STATUTORY INFORMATION

Dr Neil Ruparelia Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 11612511

Registered office: 48 St Leonards Road
Bexhill on Sea
East Sussex
TN40 1JB

The presentation currency of the financial statements is the Pound Sterling (£).


2. STATEMENT OF COMPLIANCE

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006.

3. ACCOUNTING POLICIES

Basis of preparing the financial statements
The financial statements have been prepared under the historical cost convention.

Turnover
The turnover shown in the profit and loss account represents amounts receivable for services provided during the year.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 20% on reducing balance
Computer equipment - 20% on cost

All fixed assets are initially recorded at cost.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Profit and Loss Account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


DR NEIL RUPARELIA LTD (REGISTERED NUMBER: 11612511)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 OCTOBER 2024


3. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Financial instruments
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the entity after deducting all of its financial liabilities.

Where the contractual obligations of financial instruments (including share capital) are equivalent to a similar debt instrument, those financial instruments are classed as financial liabilities. Financial liabilities are presented as such in the balance sheet. Finance costs and gains or losses relating to financial liabilities are included in the profit and loss account. Finance costs are calculated so as to produce a constant rate of return on the outstanding liability.

Where the contractual terms of share capital do not have any terms meeting the definition of a financial liability then this is classed as an equity instrument. Dividends and distributions relating to equity instruments are debited direct to equity.

4. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2023 - 2 ) .

DR NEIL RUPARELIA LTD (REGISTERED NUMBER: 11612511)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 OCTOBER 2024


5. TANGIBLE FIXED ASSETS
Plant and Computer
machinery equipment Totals
£    £    £   
COST
At 1 November 2023
and 31 October 2024 448 4,796 5,244
DEPRECIATION
At 1 November 2023 141 1,563 1,704
Charge for year 89 959 1,048
At 31 October 2024 230 2,522 2,752
NET BOOK VALUE
At 31 October 2024 218 2,274 2,492
At 31 October 2023 307 3,233 3,540

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 3,399 5,171
Other debtors 245,000 175,000
Directors' current accounts 4,278 510
Prepayments and accrued income 609 130
253,286 180,811

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Corporation tax 12,450 20,841
Other creditors 80,198 13,983
Accruals and deferred income 1,716 1,881
94,364 36,705

8. PROVISIONS FOR LIABILITIES
2024 2023
£    £   
Deferred tax
Accelerated capital allowances 623 -

DR NEIL RUPARELIA LTD (REGISTERED NUMBER: 11612511)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 OCTOBER 2024


8. PROVISIONS FOR LIABILITIES - continued

Deferred
tax
£   
Provided during year 623
Balance at 31 October 2024 623

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
100 Ordinary £1 100 100
100 Ordinary B £1 100 100
200 200

10. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 October 2024 and 31 October 2023:

2024 2023
£    £   
Dr N Ruparelia
Balance outstanding at start of year 510 252
Amounts advanced 4,278 510
Amounts repaid (510 ) (252 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 4,278 510

Loans to directors not exceeding £10,000 per director, are interest free and repayable on demand.

11. RELATED PARTY DISCLOSURES

The company is a member of two LLPs. The company has made interest free loans to the LLPs with a total balance outstanding as at 31 October 2024 of £145,000 (2023: £90,000). The company has received fees for work undertaken for the LLPs of £97,908 but these have been reduced by a share of the LLPs losses of £66,215. Included in creditors is £89,198 (2023: 13,983) in respect of the share of losses owed to the LLPs.

The director is also a director and 25% shareholder of another company. Dr Neil Ruparelia Ltd has made interest free loans to this other company with a balance as at 31 October 2024 of £100,000 (2023: £85,000).